How Will Sports Take Advantage of Augmented Reality?

On Spatial Perspectives, host Dan Cui will have a one-on-one dialog with innovators and thought leaders in the growing Spatial Reality, or Spatial Computing, market. Cui will invite guests who can discuss the real world use cases of the technology and how it could benefit mankind while exploring any drawbacks and how they might be mitigated.

 

Live sporting events are back on the menu in the wake of COVID-19 — but that doesn’t mean they’ll look the same as they did prior to the pandemic.

In addition to safety measure and other touchless innovations present at the world’s stadiums and arenas, technologies like augmented reality could be ready to make a huge impact on the way fans consume live sports.

To learn more, MarketScale invited Spatial Perspectives host Dan Cui to share his insights.

“As we get back to attending live sporting events, augmented reality offers teams, sponsors and fans a unique way of engaging with one another.

Just prior to this COVID shutdown, AT&T Stadium partnered with Nexus studios to provide location-based augmented reality visualizations throughout the stadium, giving fans a virtual way to interact with their favorite players, which enhances the overall game night experience.

But the benefits don’t stop there. All aspects of stadium and team activities can become more exciting. Halftime shows, historical game overlays, player statistics, on field rulings, even food, beverage and swag — purchasing can become part of the adventure of attending a live event infused with augmented reality.

From a marketing perspective, augmented reality clearly enhances team brand loyalty by providing sponsors innovative ways of reaching their target audiences. Keep your eyes open at the next live event you’ll be attending and join in on the fun.”

Listen to Previous Episodes of Spatial Perspectives Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More